20.1 C
New York
Monday, June 8, 2026

Tag: assessments

newssourceFORcompanyinformationcontent1marketreleases

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 

In HelloNation, Auto Industry Experts David Mantz and David Mantz Jr. Examine Choosing the Right Mechanic in Southington, Connecticut

The article explains how to evaluate transparency, consistency, and preventative maintenance when selecting an auto repair company.SOUTHINGTON, Conn., June 5, 2026 /PRNewswire/ -- What...

Orla Mining Reports Resumption of Operations at Camino Rojo

VANCOUVER, BC, June 5, 2026 /CNW/ - Orla Mining Ltd. (TSX: OLA; NYSE: ORLA) ("Orla" or the "Company") is pleased to report that the...

Altimetrik Named Product Challenger in ISG Provider Lens™ 2026 for Global Capability Center Services

BENGALURU, India, June 5, 2026 /PRNewswire/ -- Altimetrik, an AI-first digital engineering company, has been named a Product Challenger in the Design and Setup...

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer

Ocean Tomo, a Part of J.S. Held, Experts Named to the 2026 IAM Patent 1000

Intellectual Property disputes professionals named among the world's top experts by IAM.NEW YORK, June 4, 2026 /PRNewswire/ -- The 2026 IAM Patent 1000 has once...

Greenland Mines Completes Site Visit to Sarfartoq Nd-Pr Rare Earth Magnet Project in Greenland; Prepares 2026 Field Program

CHARLOTTE, N.C., June 4, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) today announced that its Greenland operations team has...

LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SaMD)

Ethics Committee Approval Received for Pivotal Study Intended to Support U.S. FDA Class II Submission for QuickScan™ Strep AVANCOUVER, BC, June 4, 2026 /CNW/...

Teacher confidence in AI grows, but call for more training to prepare students

LONDON, June 4, 2026 /PRNewswire/ -- New research from Pearson (FTSE: PSON.L), the world's lifelong learning company, suggests that UK teachers' confidence in using AI...

Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting

Assemblée Générale Mixte du 24 juin 2026 Modalités de mise à disposition des documents préparatoires à l’Assemblée

Digital University Unveils New LMS/SIS Capabilities

WASHINGTON, June 3, 2026 /PRNewswire/ -- Digital University (DU) is advancing its mission as the Department of War's (DoW) enterprise training and readiness platform by...

1606 Corp. Advances Power Acquisition as Financing Discussions Accelerate

1606 Corp. Advances Power Acquisition as Financing Discussions Accelerate

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAssessments

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers